| Literature DB >> 34909032 |
Massimo Prior1, Teresa Mercogliano1, Giorgio Pigato2, Leonardo Meneghetti1, Franca Chierichetti3, Serena Cargnel4.
Abstract
The present work depicts the case of a young man suffering from a depersonalization and derealization (DD) disorder, which mainly affects his own body. When the symptoms concern something else, they almost exclusively affect living beings. Neuropsychological and neuropsychiatric studies, as well as functional neuroanatomy studies, have led to hypothesize possible relationships among cognitive-neurofunctional alterations and symptoms of depersonalization and derealization. The present study suggests that a malfunction of the left frontal and prefrontal cortex causes deficits of working memory, producing some of the symptoms of DD.Entities:
Keywords: depersonalization; derealization; positron emission tomography; working memory
Year: 2021 PMID: 34909032 PMCID: PMC8629081 DOI: 10.36131/cnfioritieditore20210305
Source DB: PubMed Journal: Clin Neuropsychiatry ISSN: 1724-4935
Table 2
| Test | Score |
|---|---|
| Memory | |
| Buscke - Fuld (Recall from MLT) | z = -2.1 |
| Buscke - Fuld (Non Random Recall) | z = -1.8 |
| Spatial Supra-Span learning | z = -3.7 |
| Planning | |
| Tower of London | z = -7.3 |
Results of the neuropsychological assessment. In this table are reported tests z values inferior to 1.6 corresponding to α≤.05
Table 1
| Main Drug | ||
|---|---|---|
| CLOMIPRAMINE | 200 mg | 75 |
| VENLAFAXINE | 1500 mg | 45 |
| IMIPRAMINE | 150 mg | 50 |
| PAROXETINE | 20 mg | 20 |
| + | ||
| DOSULEPINE | 75 mg | 20 |
| SULPIRIDE | 400 mg | 20 |
| PERICIAZINE | 20 mg | 20 |
| TIORIDAZINE | 400 mg | 20 |
| + | ||
| CARBAMAZEPINE | 600 mg | 20 |
| PERFENAZINE | 6 mg | 20 |
| + | ||
| AMITRIPTILINE | 75 mg | 20 |
| RISPERIDONE | 6 mg | 20 |
| CLOZAPINE | 350 mg | 30 |
|
| ||
| LORAZEPAM | 75 mg | |
| DIAZEPAM | 10 mg | |
| CLONAZEPAM | 6 mg | |